Combinations with allosteric SHP2 inhibitor TNO155 to block receptor tyrosine kinase signaling

C Liu, H Lu, H Wang, A Loo, X Zhang, G Yang… - Clinical Cancer …, 2021 - AACR
Purpose: SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …
被引用次数：118 相关文章
[PDF] researchgate.net

[PDF][PDF] Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

C Liu, H Lu, H Wang, A Loo, X Zhang, G Yang… - Clin Cancer …, 2021 - researchgate.net
Purpose: SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …

Combinations with allosteric SHP2 inhibitor TNO155 to block receptor tyrosine kinase signaling

C Liu, H Lu, H Wang, A Loo… - Clinical Cancer …, 2021 - mdanderson.elsevierpure.com
Purpose: SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …

Combinations with allosteric SHP2 inhibitor TNO155 to block receptor tyrosine kinase signaling

C Liu, H Lu, H Wang, A Loo, X Zhang… - Clinical Cancer …, 2021 - oak.novartis.com
Purpose: SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …

Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

C Liu, H Lu, H Wang, A Loo, X Zhang, G Yang… - Clinical Cancer …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose:</jats: title>< jats: p>
SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine kinase …

Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.

C Liu, H Lu, H Wang, A Loo, X Zhang… - … Cancer Research: an …, 2020 - europepmc.org
Purpose SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …

Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

C Liu, H Lu, H Wang, A Loo, X Zhang… - … : an official journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …

Combinations with allosteric SHP2 inhibitor TNO155 to block receptor tyrosine kinase signaling

C Liu, H Lu, H Wang, A Loo, X Zhang… - Clinical Cancer …, 2021 - oak.novartis.com
Purpose: SHP2 inhibitors offer an appealing and novel approach to inhibit receptor tyrosine
kinase (RTK) signaling, which is the oncogenic driver in many tumors or is frequently …